Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Effect of Number of Bifunctional Chelating Agents on the Pharmacokinetics and Immunoreactivity of 177Lu-labeled Rituximab: A Systemic Study, Anti-Cancer Agents in Medicinal Chemistry, March 2018, Bentham Science Publishers,
DOI: 10.2174/1871520617666170725164530.
You can read the full text:
Contributors
The following have contributed to this page
